Tech Company Financing Transactions
Innovative Biosensors Funding Round
On 10/24/2006, Innovative Biosensors raised $2.8 million in Series A investment from Chart Venture Partners and CNF Investments.
Transaction Overview
Company Name
Announced On
10/24/2006
Transaction Type
Venture Equity
Amount
$2,750,000
Round
Series A
Investors
Chart Venture Partners (Cole VanNice)
CNF Investments (Joseph DelGuercio)
Proceeds Purpose
"Closing this financing round with CNF Investments and Chart Venture Partners enables the
company to bolster its research and development and commercialization efforts relative to the
biodefense and human clinical diagnostics markets," said Joe Hernandez, IBI's President and
CEO. "These funds will hasten the availability of rapid tests to markets that desperately need
quick, accurate results to assist with critical, time-sensitive decision-making."
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15601 Crabbs Branch Way
Rockville, MD 20855
USA
Rockville, MD 20855
USA
Phone
Website
Email Address
Overview
The BioFlash system is composed of a genetically engineered biosensor that allows for extremely rapid testing of analytes at previously unseen levels of sensitivity and specificity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Yost
Chief Financial Officer
Rigg Mohler
Browse more venture capital transactions:
Prev: 10/23/2006: Amorcyte venture capital transaction
Next: 10/24/2006: Skyrider venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs